Home | Welcome to Contract Pharma   
Last Updated Sunday, May 24 2015

Print

Breaking News

October 24, 2011
The facility is expected to be built and validated within the next two years.  Read More »
October 24, 2011
The expansion will double current capacity for pilot scale development and manufacturing  Read More »
October 24, 2011
Adds to pipeline of women’s healthcare products  Read More »
October 24, 2011
Meeker to incorporate the Rare Disease business and the Multiple Sclerosis franchise  Read More »
Gil Roth
October 21, 2011
McLeod to oversee all accounting and IT functions  Read More »
Gil Roth
October 21, 2011
Adds Late Phase Offerings  Read More »
Gil Roth
October 21, 2011
To develop new compounds in the field of botulinum toxins  Read More »
Gil Roth
October 21, 2011
Freeslate to provide high throughput research solutions  Read More »
Gil Roth
October 21, 2011
Uses Agilent tech for new suite  Read More »
October 20, 2011
Two diabetes projects valued at more than $18 million  Read More »
October 20, 2011
BioScience revenues up 9%  Read More »
October 20, 2011
Revenues up 9%  Read More »
October 20, 2011
To initiate Cbl-b target project  Read More »
October 20, 2011
Dr. Jeanne Stadler specializes in reproductive and developmental toxicology  Read More »
Gil Roth
October 19, 2011
Will divide company to pare away research-driven pharma  Read More »



Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On